STAT3 and cancer: Our results highlighted the role of post-translational modification of CDK1–STAT3 signaling in maintaining cancer stemness of PDAC and suggested that inhibition of the CDK1–STAT3 axis by fisetin helps to suppress PDAC cell proliferation through eliminating PCSC subsets.